Search details
1.
HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma.
Blood
; 128(21): 2517-2526, 2016 11 24.
Article
in English
| MEDLINE | ID: mdl-27742706
2.
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.
Blood
; 123(9): 1293-6, 2014 Feb 27.
Article
in English
| MEDLINE | ID: mdl-24345752
3.
Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2.
Blood
; 120(14): 2853-63, 2012 Oct 04.
Article
in English
| MEDLINE | ID: mdl-22915648
4.
Mechanisms of p53-mediated repression of the human polycystic kidney disease-1 promoter.
Biochim Biophys Acta
; 1799(7): 502-9, 2010 Jul.
Article
in English
| MEDLINE | ID: mdl-20388565
5.
Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia.
Cancer Cell
; 28(1): 29-41, 2015 Jul 13.
Article
in English
| MEDLINE | ID: mdl-26175414
6.
TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling.
Database (Oxford)
; 2014: bau007, 2014.
Article
in English
| MEDLINE | ID: mdl-24573880
7.
Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation.
Nat Genet
; 46(6): 618-23, 2014 Jun.
Article
in English
| MEDLINE | ID: mdl-24747640
8.
BCL2 suppresses PARP1 function and nonapoptotic cell death.
Cancer Res
; 72(16): 4193-203, 2012 Aug 15.
Article
in English
| MEDLINE | ID: mdl-22689920
9.
Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition.
J Exp Med
; 209(2): 259-73, 2012 Feb 13.
Article
in English
| MEDLINE | ID: mdl-22271575
10.
The polycystic kidney disease-1 gene is a target for p53-mediated transcriptional repression.
J Biol Chem
; 281(42): 31234-44, 2006 Oct 20.
Article
in English
| MEDLINE | ID: mdl-16931520
Results
1 -
10
de 10
1
Next >
>>